Santhera Pharmaceuticals Ag
(OTC) SPHDF
Santhera Pharmaceuticals Ag Financials at a Glance
Market Cap
$251.60M
Revenue (TTM)
$162.57M
Net Income (TTM)
$2.69M
EPS (TTM)
$-5.92
P/E Ratio
-3.02
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$17.90
Volume
1,400
Open
$17.90
Price
$17.90
Volume
1,400
Open
$17.90
Previous Close
$17.90
Daily Range
$17.90 - $17.90
52-Week Range
$12.28 - $22.04
Dividend
$0.00
Beta (Volatility)
-0.04 (Low)
Price
$17.90
Volume
1,400
Open
$17.90
Previous Close
$17.90
Daily Range
$17.90 - $17.90
52-Week Range
$12.28 - $22.04
SPHDF News
SPHDF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Santhera Pharmaceuticals Ag
Industry
Biotechnology
Sector
Health CareEmployees
78.5
CEO
Dario Eklund
Website
www.santhera.comHeadquarters
Pratteln, 4133, CH
SPHDF Financials
Key Financial Metrics (TTM)
Gross Margin
12%
Operating Margin
-1%
Net Income Margin
-1%
Return on Equity
-301%
Return on Capital
-70%
Return on Assets
-50%
Earnings Yield
-33.11%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$251.60M
Shares Outstanding
14.06M
Volume
1.40K
Short Interest
0.00%
Avg. Volume
201.639
Financials (TTM)
Gross Profit
$22.96M
Operating Income
$33.38M
EBITDA
$15.89M
Operating Cash Flow
$35.53M
Capital Expenditure
$151.00K
Free Cash Flow
$35.68M
Cash & ST Invst.
$40.92M
Total Debt
$41.17M
Santhera Pharmaceuticals Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.01M
+509.6%
Gross Profit
$8.11M
-575.7%
Gross Margin
-33.77%
N/A
Market Cap
$251.60M
N/A
Market Cap/Employee
$3.23M
N/A
Employees
78
N/A
Net Income
$38.83M
-66.4%
EBITDA
$32.61M
-140.1%
Quarterly Fundamentals
Net Cash
$22.82M
+42.7%
Accounts Receivable
$11.20M
+468.2%
Inventory
$26.03M
+291.4%
Long Term Debt
$33.78M
+73.1%
Short Term Debt
$7.44M
-66.2%
Return on Assets
-50.12%
N/A
Return on Invested Capital
-69.92%
N/A
Free Cash Flow
$20.67M
-34.6%
Operating Cash Flow
$20.60M
-34.1%